Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model

BB. Endaya, PY. Lam, AC. Meedeniya, J. Neuzil,

. 2016 ; 10 (1) : 126-37. [pub] 20150910

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001006

Intratumor heterogeneity is a primary feature of high-grade gliomas, complicating their therapy. As accumulating evidence suggests that intratumor heterogeneity is a consequence of cellular subsets with different cycling frequencies, we developed a method for transcriptional profiling of gliomas, using a novel technique to dissect the tumors into two fundamental cellular subsets, namely, the proliferating and non-proliferating cell fractions. The tumor fractions were sorted whilst maintaining their molecular integrity, by incorporating the thymidine analog 5-ethynyl-2'-deoxyuridine into actively dividing cells. We sorted the actively dividing versus non-dividing cells from cultured glioma cells, and parental and clonally derived orthotopic tumors, and analyzed them for a number of transcripts. While there was no significant difference in the transcriptional profiles between the two cellular subsets in cultured glioma cells, we demonstrate ∼2-6 fold increase in transcripts of cancer and neuronal stem cell and tumor cell migration/invasion markers, and ∼2-fold decrease in transcripts of markers of hypoxia and their target genes, in the dividing tumor cells of the orthotopic glioma when compared to their non-proliferative counterparts. This suggests the influence of the brain microenvironment in transcriptional regulation and, thereby, the physiology of glioma cells in vivo. When clonal glioma cells were derived from a parental glioma and the resultant orthotopic tumors were compared, their transcriptional profiles were closely correlated to tumor aggression and consequently, survival of the experimental animals. This study demonstrates the resolution of intratumor heterogeneity for profiling studies based on cell proliferation, a defining feature of cancers, with implications for treatment design.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001006
003      
CZ-PrNML
005      
20170119123833.0
007      
ta
008      
170103s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.molonc.2015.09.001 $2 doi
024    7_
$a 10.1016/j.molonc.2015.09.001 $2 doi
035    __
$a (PubMed)26388584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Endaya, Berwini B $u School of Medical Science, Griffith University, Southport, Qld, 4222, Australia.
245    10
$a Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model / $c BB. Endaya, PY. Lam, AC. Meedeniya, J. Neuzil,
520    9_
$a Intratumor heterogeneity is a primary feature of high-grade gliomas, complicating their therapy. As accumulating evidence suggests that intratumor heterogeneity is a consequence of cellular subsets with different cycling frequencies, we developed a method for transcriptional profiling of gliomas, using a novel technique to dissect the tumors into two fundamental cellular subsets, namely, the proliferating and non-proliferating cell fractions. The tumor fractions were sorted whilst maintaining their molecular integrity, by incorporating the thymidine analog 5-ethynyl-2'-deoxyuridine into actively dividing cells. We sorted the actively dividing versus non-dividing cells from cultured glioma cells, and parental and clonally derived orthotopic tumors, and analyzed them for a number of transcripts. While there was no significant difference in the transcriptional profiles between the two cellular subsets in cultured glioma cells, we demonstrate ∼2-6 fold increase in transcripts of cancer and neuronal stem cell and tumor cell migration/invasion markers, and ∼2-fold decrease in transcripts of markers of hypoxia and their target genes, in the dividing tumor cells of the orthotopic glioma when compared to their non-proliferative counterparts. This suggests the influence of the brain microenvironment in transcriptional regulation and, thereby, the physiology of glioma cells in vivo. When clonal glioma cells were derived from a parental glioma and the resultant orthotopic tumors were compared, their transcriptional profiles were closely correlated to tumor aggression and consequently, survival of the experimental animals. This study demonstrates the resolution of intratumor heterogeneity for profiling studies based on cell proliferation, a defining feature of cancers, with implications for treatment design.
650    _2
$a zvířata $7 D000818
650    _2
$a nádory mozku $x patologie $7 D001932
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a proliferace buněk $7 D049109
650    12
$a stanovení celkové genové exprese $7 D020869
650    _2
$a gliom $x patologie $7 D005910
650    _2
$a heterografty $7 D064593
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    12
$a genetická transkripce $7 D014158
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lam, Paula Y P $u Laboratory of Cancer Gene Therapy, National Cancer Centre, 169610, Singapore.
700    1_
$a Meedeniya, Adrian C B $u School of Medical Science, Griffith University, Southport, Qld, 4222, Australia. Electronic address: a.meedeniya@griffith.edu.au.
700    1_
$a Neuzil, Jiri $u School of Medical Science, Griffith University, Southport, Qld, 4222, Australia; Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, 142 20, Czech Republic. Electronic address: j.neuzil@griffith.edu.au.
773    0_
$w MED00167281 $t Molecular oncology $x 1878-0261 $g Roč. 10, č. 1 (2016), s. 126-37
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26388584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170119123942 $b ABA008
999    __
$a ok $b bmc $g 1180146 $s 961573
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 10 $c 1 $d 126-37 $e 20150910 $i 1878-0261 $m Molecular oncology $n Mol Oncol $x MED00167281
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Možnosti archivace